Trial Profile
Study of the influences of Yokukansan for sleep disturbance in dementia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2015
Price :
$35
*
At a glance
- Drugs TJ 54 (Primary)
- Indications Dementia
- Focus Pharmacodynamics
- 08 Jan 2013 Planned end date added (1 Aug 2013) as reported by University Hospital Medical Information Network - Japan.
- 26 Oct 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 05 Sep 2011 New trial record